Literature DB >> 27890240

Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.

Jennifer M Huang1, Ijeuru Chikeka1, Thomas J Hornyak2.   

Abstract

Melanocytic nevi represent benign clonal proliferations of the melanocytes in the skin that usually remain stable in size and behavior or disappear during life. Infrequently, melanocytic nevi undergo malignant transformation to melanoma. Understanding molecular and cellular mechanisms underlying oncogene-induced senescence should help identify pathways underlying melanoma development, leading to the development of new strategies for melanoma prevention and early detection. Published by Elsevier Inc.

Entities:  

Keywords:  Melanocyte; Melanoma; Nevi; Oncogene; Senescence

Mesh：

Year:  2017        PMID： 27890240      PMCID： PMC5391772          DOI： 10.1016/j.det.2016.08.001

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  48 in total

1.  Regulation of human epidermal stem cell proliferation and senescence requires polycomb- dependent and -independent functions of Cbx4.

Authors:  Nuno Miguel Luis; Lluis Morey; Stefania Mejetta; Gloria Pascual; Peggy Janich; Bernd Kuebler; Luca Cozutto; Guglielmo Roma; Elisabete Nascimento; Michaela Frye; Luciano Di Croce; Salvador Aznar Benitah
Journal:  Cell Stem Cell       Date:  2011-09-02       Impact factor: 24.633

2.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

3.  Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.

Authors:  H Kittler; H Pehamberger; K Wolff; M Binder
Journal:  J Am Acad Dermatol       Date:  2000-09       Impact factor: 11.527

4.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

5.  Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia.

Authors:  A E Grulich; V Bataille; A J Swerdlow; J A Newton-Bishop; J Cuzick; P Hersey; W H McCarthy
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

6.  EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.

Authors:  Tao Fan; Shunlin Jiang; Nancy Chung; Ali Alikhan; Christina Ni; Chyi-Chia Richard Lee; Thomas J Hornyak
Journal:  Mol Cancer Res       Date:  2011-03-07       Impact factor: 5.852

7.  Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma.

Authors:  Xiaoqi Xie; Ju Yong Koh; Sandy Price; Eileen White; Janice M Mehnert
Journal:  Cancer Discov       Date:  2015-02-11       Impact factor: 39.397

8.  Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.

Authors:  R W Sagebiel
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

9.  Cutaneous melanomas associated with nevi.

Authors:  Caroline Bevona; William Goggins; Timothy Quinn; Julie Fullerton; Hensin Tsao
Journal:  Arch Dermatol       Date:  2003-12

Review 10.  EZH2: an emerging role in melanoma biology and strategies for targeted therapy.

Authors:  Jessamy Tiffen; Stuart J Gallagher; Peter Hersey
Journal:  Pigment Cell Melanoma Res       Date:  2014-06-27       Impact factor: 4.693
View more
  6 in total

Review 1.  Focus on the Contribution of Oxidative Stress in Skin Aging.

Authors:  Federica Papaccio; Andrea D Arino; Silvia Caputo; Barbara Bellei
Journal:  Antioxidants (Basel)       Date:  2022-06-06

Review 2.  Detection of Gene Mutations in Liquid Biopsy of Melanoma Patients: Overview and Future Perspectives.

Authors:  Nasr Alrabadi; Razan Haddad; Ahmed K Alomari
Journal:  Curr Treat Options Oncol       Date:  2020-02-11

3.  Thymine DNA glycosylase as a novel target for melanoma.

Authors:  Pietro Mancuso; Rossella Tricarico; Vikram Bhattacharjee; Laura Cosentino; Yuwaraj Kadariya; Jaroslav Jelinek; Emmanuelle Nicolas; Margret Einarson; Neil Beeharry; Karthik Devarajan; Richard A Katz; Dorjbal G Dorjsuren; Hongmao Sun; Anton Simeonov; Antonio Giordano; Joseph R Testa; Guillaume Davidson; Irwin Davidson; Lionel Larue; Robert W Sobol; Timothy J Yen; Alfonso Bellacosa
Journal:  Oncogene       Date:  2019-01-23       Impact factor: 8.756

Review 4.  Cancer progression as a learning process.

Authors:  Aseel Shomar; Omri Barak; Naama Brenner
Journal:  iScience       Date:  2022-02-14

Review 5.  Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances.

Authors:  Strahil Strashilov; Angel Yordanov
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

6.  Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.

Authors:  Rolando Ruiz-Vega; Chi-Fen Chen; Emaad Razzak; Priya Vasudeva; Tatiana B Krasieva; Jessica Shiu; Michael G Caldwell; Huaming Yan; John Lowengrub; Anand K Ganesan; Arthur D Lander
Journal:  Elife       Date:  2020-10-13       Impact factor: 8.713
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.